Spinchem AB is a spinoff company from Umeå University, and UBI-alumni, who has developed and successfully introduced an all new technology for chemical reactions in everything from a laboratory setting to full scale industrial operations.
SpinChem’s vision is to transform the world by providing the simplest, fastest, most stable and resource-efficient technical solutions, as a catalyst for the global process chemistry industry. An they can already boast of users from some of the most high profile corporations in the industry – like Astrazeneca, Glaxosmithkline, Sanofi, Lilly, Pfizer and Merck.
New release for biocatalysis in Life sciences
The second week of May Spinchem officially launched their new product segment and announced their collaboration with Purolite Life Sciences. The new catalyst cartridges in combination with the RBR systems will make it easier and faster for customers to investigate and optimize manufacturing processes where immobilized enzymes are used for biocatalysis. Examples of such processes are found in the manufacturing of ingredients for pharmaceuticals, cosmetics and nutrition.
– We are very happy about the cooperation with Purolite Life Sciences. The agreement is a strong confirmation of the benefits with our RBR technology and will help us to reach new customer groups with the SpinChem® products, says Dr. Emil Byström, CEO at SpinChem AB.
– There is a large interest in the cartridge concept and customers that want to order, he adds.
Their new partner in business are also very enthusiastic about the collaboration.
– The products represent a new concept in biocatalysis which is facilitating the use of immobilized enzymes. I am sure customers will enjoy this new experience, says Dr. Alessandra Basso, Lifetech Manager at Purolite Life Sciences AB.
Read the full press release story at Biotech Umeå or get all the details about the cartridges directly at SpinChems website.